Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1057 | 1028 | 1118 | 1075 | 1165 | 1486 |
Fund Return | 5.69% | 2.83% | 11.78% | 2.45% | 3.1% | 4.04% |
Place in category | 481 | 656 | 392 | 160 | 101 | 23 |
% in Category | 46 | 61 | 37 | 20 | 16 | 5 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Euro High Yield Class Z EUR Cap | 3.01B | 6.31 | 3.22 | 4.82 | ||
Candriam Bonds Euro High Yield Clas | 3.01B | 5.21 | 1.85 | 3.46 | ||
Euro High Yield Class C EUR Cap | 3.01B | 5.25 | 1.94 | 3.57 | ||
Euro High Yield Class C EUR Dis | 3.01B | 5.20 | 1.89 | 3.49 | ||
Euro High Yield Class I EUR Cap | 3.01B | 5.83 | 2.40 | 3.96 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
N1 European High Yield Bond Fund BC | 3.05B | 6.28 | 1.57 | 3.49 | ||
N1 European High Yield Bond Fund Bi | 3.05B | 6.45 | 1.80 | 3.70 | ||
N1 European High Yield Bond Fund Be | 3.05B | 5.96 | 1.18 | 3.06 | ||
Nordea 1 European High Yield Bond x | 3.05B | 6.98 | 2.47 | 4.38 | ||
LU0229519474 | 3.05B | 5.36 | 0.42 | 2.29 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Candriam Monétaire SICAV V C | FR0013113222 | 8.26 | - | - | |
Teva Pharmaceutical Finance Netherlands II B.V 4.375% | XS2406607171 | 4.05 | - | - | |
Lorca Telecom Bondco S.A.U. 4% | XS2240463674 | 2.77 | - | - | |
Nidda Healthcare Holding GmbH 7.5% | XS2550063478 | 2.55 | - | - | |
Verisure Holding AB (publ) 3.875% | XS2204842384 | 2.26 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | BUY | BUY |
Summary | Strong Buy | Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review